c-Myc degradation induced by DNA damage results in apoptosis of CHO cells

被引:0
|
作者
Man-Rong Jiang
Yuan-Chao Li
Ying Yang
Jia-Rui Wu
机构
[1] Laboratory of Molecular Cell Biology,
[2] Institute of Biochemistry and Cell Biology,undefined
[3] Shanghai Institutes for Biological Sciences,undefined
[4] Chinese Academy of Sciences,undefined
[5] Institute of Materia Medica,undefined
[6] Shanghai Institutes for Biological Sciences,undefined
[7] Chinese Academy of Sciences,undefined
来源
Oncogene | 2003年 / 22卷
关键词
c-Myc; apoptosis; DNA damage; CHO cell; tripchlorolide;
D O I
暂无
中图分类号
学科分类号
摘要
Although tripchlorolide (TC), a compound purified from a Chinese herb Tripterygium Wilfordii Hook, has been demonstrated to be a potent antitumor agent, its mechanisms of action are unknown. The present study shows that TC induces apoptosis of Chinese Hamster Ovary (CHO) cells. Most strikingly, TC was particularly potent in inducing apoptosis of the UV41 mutant CHO cells, which are deficient in the ERCC4 gene encoding a nucleotide excision repair protein. TC caused a higher level of DNA damage in UV41 cells than those in the wild-type CHO cells or EM9 cells, which are deficient in single-strand break repair. These results provided a critical link between apoptotic hypersensitivity and DNA damage in defective nucleotide excision repair pathway of UV41 cells by TC treatment. Further analysis showed that degradation of the c-Myc protein in TC-treated UV41 cells was much stronger than those in the wild-type CHOAA8 and the EM9. A proteasome inhibitor, MG132, reduced both the degradation of c-Myc and apoptosis in TC-treated UV41 cells. Expression of exogenous c-Myc also inhibited apoptosis of TC-treated UV41 cells. These results indicate that c-Myc degradation induced by DNA damage in the presence of TC contributes to induction of apoptosis of UV41 cells.
引用
收藏
页码:3252 / 3259
页数:7
相关论文
共 50 条
  • [1] C-Myc degradation induced by DNA damage results in apoptosis of CHO cells
    Jiang, MR
    Lie, YC
    Yang, Y
    Wu, JR
    ONCOGENE, 2003, 22 (21) : 3252 - 3259
  • [2] Dihydroartemisinin accelerates c-Myc oncoprotein degradation and induces apoptosis in c-Myc overexpressed tumor cells
    Lu, Jin-Jian
    Meng, Ling-Hua
    Zhu, Cai-Hua
    Tong, Lin-Jiang
    Lin, Li-Ping
    Ding, Jian
    CANCER RESEARCH, 2009, 69
  • [3] Caspases in c-Myc induced apoptosis
    Jarvinen, K.
    Hotti, A.
    Holtta, E.
    EJC SUPPLEMENTS, 2010, 8 (05): : 134 - 134
  • [4] Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
    T J Phesse
    K B Myant
    A M Cole
    R A Ridgway
    H Pearson
    V Muncan
    G R van den Brink
    K H Vousden
    R Sears
    L T Vassilev
    A R Clarke
    O J Sansom
    Cell Death & Differentiation, 2014, 21 : 956 - 966
  • [5] Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo
    Phesse, T. J.
    Myant, K. B.
    Cole, A. M.
    Ridgway, R. A.
    Pearson, H.
    Muncan, V.
    van den Brink, G. R.
    Vousden, K. H.
    Sears, R.
    Vassilev, L. T.
    Clarke, A. R.
    Sansom, O. J.
    CELL DEATH AND DIFFERENTIATION, 2014, 21 (06): : 956 - 966
  • [7] DNA damage, apoptosis and C-myc, C-fos, and C-jun overexpression induced by selenium in rat hepatocytes
    Yu, Ri-An
    Yang, Cheng-Feng
    Chen, Xue-Min
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2006, 19 (03) : 197 - 204
  • [8] Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells
    Lu, Jin-Jian
    Meng, Ling-Hua
    Shankavaram, Uma T.
    Zhua, Cai-Hua
    Tong, Lin-Jiang
    Chen, Guang
    Lin, Li-Ping
    Weinstein, John N.
    Ding, Jian
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (01) : 22 - 30
  • [9] c-Myc is necessary for DNA damage-induced apoptosis in the G2 phase of the cell cycle
    Adachi, S
    Obaya, AJ
    Han, ZY
    Ramos-Desimone, N
    Wyche, JH
    Sedivy, JM
    MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (15) : 4929 - 4937
  • [10] C-MYC AND APOPTOSIS
    PACKHAM, G
    CLEVELAND, JL
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1995, 1242 (01): : 11 - 28